Skip to main navigation
Skip to search
Skip to main content
UTMB Health Research Expert Profiles Home
Help & FAQ
Home
Experts
Departments
Equipment
Projects/Grants
Publications
Activities
Press/Media
Honors
Impacts
Search by expertise, name or affiliation
Near Sequence Homology Does Not Guarantee siRNA Cross-Species Efficacy
Iris Valeria Rivera Flores
, Kathryn Monopoli
, Samuel Jackson
, Dimas Echeverria
,
Daniel O’Reilly
, Robert H. Brown
, Anastasia Khvorova
Research output
:
Contribution to journal
›
Article
›
peer-review
1
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Near Sequence Homology Does Not Guarantee siRNA Cross-Species Efficacy'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Small Interfering RNA (siRNA)
100%
Sequence Homology
100%
Cross-species
100%
Therapeutic Leads
33%
Inflammation
16%
Sheep
16%
Preclinical Development
16%
Superoxide Dismutase 1 (SOD1)
16%
Gene Targeting
16%
MiRNA Target
16%
Drug Class
16%
Novel Class
16%
Sequence Position
16%
Human Genes
16%
Clinical Progress
16%
Janus Kinase 1 (JAK1)
16%
Active Compounds
16%
Therapeutic Model
16%
Focused Screening
16%
Sequence Mismatch
16%
Conversion Strategy
16%
Sequence number
16%
Cross-species Activity
16%
Biochemistry, Genetics and Molecular Biology
Sequence Homology
100%
Small Interfering RNA
100%
Small Interfering RNA
100%
Animal Model
20%
SOD1
20%
Preclinical Study
20%
Immunology and Microbiology
Sequence Homology
100%
Ribonucleic Acid
100%
Cell Line
20%
Preclinical Study
20%
Pharmacology, Toxicology and Pharmaceutical Science
Small Interfering RNA
100%
Inflammation
16%
Lead Compound
16%
Amyotrophic Lateral Sclerosis
16%